fura-2-am has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubi, N; Fishman, D; Gheber, L; Hershfinkel, M; Sekler, I | 1 |
| Huang, JK; Jan, CR | 1 |
2 other study(ies) available for fura-2-am and Prostatic Neoplasms
| Article | Year |
|---|---|
Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
Topics: Animals; Calcium; Calcium Signaling; Cell Proliferation; Cell Survival; Enzyme Activation; Fura-2; Humans; Immunoblotting; Male; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured; Zinc Compounds | 2008 |
Mechanism of estrogens-induced increases in intracellular Ca(2+) in PC3 human prostate cancer cells.
Topics: Antineoplastic Agents, Hormonal; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrenes; Fluorescent Dyes; Fura-2; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Pyrrolidinones; Thapsigargin; Tumor Cells, Cultured; Uncoupling Agents | 2001 |